Global Depression Drugs Supply, Demand and Key Producers, 2024-2030

Description

The global Depression Drugs market size is expected to reach $ 21350 million by 2030, rising at a market growth of 2.8% CAGR during the forecast period (2024-2030).

Global Depression Drugs key players include Intellipharmaceutics, Pfizer, Eli Lilly, Astrazeneca, Lundbeck, etc. Global top five manufacturers hold a share over 35%.

North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share about 50%.

In terms of product, SSRIs is the largest segment, with a share over 45%. And in terms of application, the largest application is Hospitals, followed by Clinics, etc.

Depression is a mental health issue. It’s a condition that starts most often in early adulthood. It’s also more common in women. However, anyone at any age may suffer from depression. Depression affects the brain, so drugs that work in the brain may offer hope. Common antidepressants may help ease your symptoms, but there are many other options as well. Each drug used to treat depression works by balancing certain chemicals in your brain called neurotransmitters. Depression Drugs is drugs used for Depression.

This report studies the global Depression Drugs demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Depression Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Depression Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Depression Drugs total market, 2019-2030, (USD Million)
Global Depression Drugs total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Depression Drugs total market, key domestic companies and share, (USD Million)
Global Depression Drugs revenue by player and market share 2019-2024, (USD Million)
Global Depression Drugs total market by Type, CAGR, 2019-2030, (USD Million)
Global Depression Drugs total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Depression Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Intellipharmaceutics, Pfizer, Eli Lilly, Astrazeneca, Lundbeck, Allergan, GSK, Otsuka Pharmaceutical and Takeda, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Depression Drugs market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Depression Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Depression Drugs Market, Segmentation by Type
    SSRIs
    SNRIs
    Others

Global Depression Drugs Market, Segmentation by Application
    Hospitals
    Clinics
    Others

Companies Profiled:
    Intellipharmaceutics
    Pfizer
    Eli Lilly
    Astrazeneca
    Lundbeck
    Allergan
    GSK
    Otsuka Pharmaceutical
    Takeda
    NHU Group
    Shionogi
    APOTEX
    Kanghong Pharma
    HUAHAI

Key Questions Answered
1. How big is the global Depression Drugs market?
2. What is the demand of the global Depression Drugs market?
3. What is the year over year growth of the global Depression Drugs market?
4. What is the total value of the global Depression Drugs market?
5. Who are the major players in the global Depression Drugs market?

Table of Contents

1 Supply Summary
    1.1 Depression Drugs Introduction
    1.2 World Depression Drugs Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Depression Drugs Total Market by Region (by Headquarter Location)
        1.3.1 World Depression Drugs Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Depression Drugs Market Size (2019-2030)
        1.3.3 China Depression Drugs Market Size (2019-2030)
        1.3.4 Europe Depression Drugs Market Size (2019-2030)
        1.3.5 Japan Depression Drugs Market Size (2019-2030)
        1.3.6 South Korea Depression Drugs Market Size (2019-2030)
        1.3.7 ASEAN Depression Drugs Market Size (2019-2030)
        1.3.8 India Depression Drugs Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Depression Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Depression Drugs Major Market Trends

2 Demand Summary
    2.1 World Depression Drugs Consumption Value (2019-2030)
    2.2 World Depression Drugs Consumption Value by Region
        2.2.1 World Depression Drugs Consumption Value by Region (2019-2024)
        2.2.2 World Depression Drugs Consumption Value Forecast by Region (2025-2030)
    2.3 United States Depression Drugs Consumption Value (2019-2030)
    2.4 China Depression Drugs Consumption Value (2019-2030)
    2.5 Europe Depression Drugs Consumption Value (2019-2030)
    2.6 Japan Depression Drugs Consumption Value (2019-2030)
    2.7 South Korea Depression Drugs Consumption Value (2019-2030)
    2.8 ASEAN Depression Drugs Consumption Value (2019-2030)
    2.9 India Depression Drugs Consumption Value (2019-2030)

3 World Depression Drugs Companies Competitive Analysis
    3.1 World Depression Drugs Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Depression Drugs Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Depression Drugs in 2023
        3.2.3 Global Concentration Ratios (CR8) for Depression Drugs in 2023
    3.3 Depression Drugs Company Evaluation Quadrant
    3.4 Depression Drugs Market: Overall Company Footprint Analysis
        3.4.1 Depression Drugs Market: Region Footprint
        3.4.2 Depression Drugs Market: Company Product Type Footprint
        3.4.3 Depression Drugs Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Depression Drugs Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Depression Drugs Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Depression Drugs Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Depression Drugs Consumption Value Comparison
        4.2.1 United States VS China: Depression Drugs Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Depression Drugs Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Depression Drugs Companies and Market Share, 2019-2024
        4.3.1 United States Based Depression Drugs Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Depression Drugs Revenue, (2019-2024)
    4.4 China Based Companies Depression Drugs Revenue and Market Share, 2019-2024
        4.4.1 China Based Depression Drugs Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Depression Drugs Revenue, (2019-2024)
    4.5 Rest of World Based Depression Drugs Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Depression Drugs Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Depression Drugs Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Depression Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 SSRIs
        5.2.2 SNRIs
        5.2.3 Others
    5.3 Market Segment by Type
        5.3.1 World Depression Drugs Market Size by Type (2019-2024)
        5.3.2 World Depression Drugs Market Size by Type (2025-2030)
        5.3.3 World Depression Drugs Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Depression Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospitals
        6.2.2 Clinics
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Depression Drugs Market Size by Application (2019-2024)
        6.3.2 World Depression Drugs Market Size by Application (2025-2030)
        6.3.3 World Depression Drugs Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Intellipharmaceutics
        7.1.1 Intellipharmaceutics Details
        7.1.2 Intellipharmaceutics Major Business
        7.1.3 Intellipharmaceutics Depression Drugs Product and Services
        7.1.4 Intellipharmaceutics Depression Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Intellipharmaceutics Recent Developments/Updates
        7.1.6 Intellipharmaceutics Competitive Strengths & Weaknesses
    7.2 Pfizer
        7.2.1 Pfizer Details
        7.2.2 Pfizer Major Business
        7.2.3 Pfizer Depression Drugs Product and Services
        7.2.4 Pfizer Depression Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Pfizer Recent Developments/Updates
        7.2.6 Pfizer Competitive Strengths & Weaknesses
    7.3 Eli Lilly
        7.3.1 Eli Lilly Details
        7.3.2 Eli Lilly Major Business
        7.3.3 Eli Lilly Depression Drugs Product and Services
        7.3.4 Eli Lilly Depression Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Eli Lilly Recent Developments/Updates
        7.3.6 Eli Lilly Competitive Strengths & Weaknesses
    7.4 Astrazeneca
        7.4.1 Astrazeneca Details
        7.4.2 Astrazeneca Major Business
        7.4.3 Astrazeneca Depression Drugs Product and Services
        7.4.4 Astrazeneca Depression Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Astrazeneca Recent Developments/Updates
        7.4.6 Astrazeneca Competitive Strengths & Weaknesses
    7.5 Lundbeck
        7.5.1 Lundbeck Details
        7.5.2 Lundbeck Major Business
        7.5.3 Lundbeck Depression Drugs Product and Services
        7.5.4 Lundbeck Depression Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Lundbeck Recent Developments/Updates
        7.5.6 Lundbeck Competitive Strengths & Weaknesses
    7.6 Allergan
        7.6.1 Allergan Details
        7.6.2 Allergan Major Business
        7.6.3 Allergan Depression Drugs Product and Services
        7.6.4 Allergan Depression Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Allergan Recent Developments/Updates
        7.6.6 Allergan Competitive Strengths & Weaknesses
    7.7 GSK
        7.7.1 GSK Details
        7.7.2 GSK Major Business
        7.7.3 GSK Depression Drugs Product and Services
        7.7.4 GSK Depression Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 GSK Recent Developments/Updates
        7.7.6 GSK Competitive Strengths & Weaknesses
    7.8 Otsuka Pharmaceutical
        7.8.1 Otsuka Pharmaceutical Details
        7.8.2 Otsuka Pharmaceutical Major Business
        7.8.3 Otsuka Pharmaceutical Depression Drugs Product and Services
        7.8.4 Otsuka Pharmaceutical Depression Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Otsuka Pharmaceutical Recent Developments/Updates
        7.8.6 Otsuka Pharmaceutical Competitive Strengths & Weaknesses
    7.9 Takeda
        7.9.1 Takeda Details
        7.9.2 Takeda Major Business
        7.9.3 Takeda Depression Drugs Product and Services
        7.9.4 Takeda Depression Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Takeda Recent Developments/Updates
        7.9.6 Takeda Competitive Strengths & Weaknesses
    7.10 NHU Group
        7.10.1 NHU Group Details
        7.10.2 NHU Group Major Business
        7.10.3 NHU Group Depression Drugs Product and Services
        7.10.4 NHU Group Depression Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 NHU Group Recent Developments/Updates
        7.10.6 NHU Group Competitive Strengths & Weaknesses
    7.11 Shionogi
        7.11.1 Shionogi Details
        7.11.2 Shionogi Major Business
        7.11.3 Shionogi Depression Drugs Product and Services
        7.11.4 Shionogi Depression Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Shionogi Recent Developments/Updates
        7.11.6 Shionogi Competitive Strengths & Weaknesses
    7.12 APOTEX
        7.12.1 APOTEX Details
        7.12.2 APOTEX Major Business
        7.12.3 APOTEX Depression Drugs Product and Services
        7.12.4 APOTEX Depression Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 APOTEX Recent Developments/Updates
        7.12.6 APOTEX Competitive Strengths & Weaknesses
    7.13 Kanghong Pharma
        7.13.1 Kanghong Pharma Details
        7.13.2 Kanghong Pharma Major Business
        7.13.3 Kanghong Pharma Depression Drugs Product and Services
        7.13.4 Kanghong Pharma Depression Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Kanghong Pharma Recent Developments/Updates
        7.13.6 Kanghong Pharma Competitive Strengths & Weaknesses
    7.14 HUAHAI
        7.14.1 HUAHAI Details
        7.14.2 HUAHAI Major Business
        7.14.3 HUAHAI Depression Drugs Product and Services
        7.14.4 HUAHAI Depression Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 HUAHAI Recent Developments/Updates
        7.14.6 HUAHAI Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Depression Drugs Industry Chain
    8.2 Depression Drugs Upstream Analysis
    8.3 Depression Drugs Midstream Analysis
    8.4 Depression Drugs Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Depression Drugs Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Depression Drugs Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Depression Drugs Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Depression Drugs Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Depression Drugs Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Depression Drugs Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Depression Drugs Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Depression Drugs Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Depression Drugs Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Depression Drugs Players in 2023
    Table 12. World Depression Drugs Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Depression Drugs Company Evaluation Quadrant
    Table 14. Head Office of Key Depression Drugs Player
    Table 15. Depression Drugs Market: Company Product Type Footprint
    Table 16. Depression Drugs Market: Company Product Application Footprint
    Table 17. Depression Drugs Mergers & Acquisitions Activity
    Table 18. United States VS China Depression Drugs Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Depression Drugs Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Depression Drugs Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Depression Drugs Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Depression Drugs Revenue Market Share (2019-2024)
    Table 23. China Based Depression Drugs Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Depression Drugs Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Depression Drugs Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Depression Drugs Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Depression Drugs Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Depression Drugs Revenue Market Share (2019-2024)
    Table 29. World Depression Drugs Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Depression Drugs Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Depression Drugs Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Depression Drugs Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Depression Drugs Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Depression Drugs Market Size by Application (2025-2030) & (USD Million)
    Table 35. Intellipharmaceutics Basic Information, Area Served and Competitors
    Table 36. Intellipharmaceutics Major Business
    Table 37. Intellipharmaceutics Depression Drugs Product and Services
    Table 38. Intellipharmaceutics Depression Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Intellipharmaceutics Recent Developments/Updates
    Table 40. Intellipharmaceutics Competitive Strengths & Weaknesses
    Table 41. Pfizer Basic Information, Area Served and Competitors
    Table 42. Pfizer Major Business
    Table 43. Pfizer Depression Drugs Product and Services
    Table 44. Pfizer Depression Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Pfizer Recent Developments/Updates
    Table 46. Pfizer Competitive Strengths & Weaknesses
    Table 47. Eli Lilly Basic Information, Area Served and Competitors
    Table 48. Eli Lilly Major Business
    Table 49. Eli Lilly Depression Drugs Product and Services
    Table 50. Eli Lilly Depression Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Eli Lilly Recent Developments/Updates
    Table 52. Eli Lilly Competitive Strengths & Weaknesses
    Table 53. Astrazeneca Basic Information, Area Served and Competitors
    Table 54. Astrazeneca Major Business
    Table 55. Astrazeneca Depression Drugs Product and Services
    Table 56. Astrazeneca Depression Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Astrazeneca Recent Developments/Updates
    Table 58. Astrazeneca Competitive Strengths & Weaknesses
    Table 59. Lundbeck Basic Information, Area Served and Competitors
    Table 60. Lundbeck Major Business
    Table 61. Lundbeck Depression Drugs Product and Services
    Table 62. Lundbeck Depression Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Lundbeck Recent Developments/Updates
    Table 64. Lundbeck Competitive Strengths & Weaknesses
    Table 65. Allergan Basic Information, Area Served and Competitors
    Table 66. Allergan Major Business
    Table 67. Allergan Depression Drugs Product and Services
    Table 68. Allergan Depression Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Allergan Recent Developments/Updates
    Table 70. Allergan Competitive Strengths & Weaknesses
    Table 71. GSK Basic Information, Area Served and Competitors
    Table 72. GSK Major Business
    Table 73. GSK Depression Drugs Product and Services
    Table 74. GSK Depression Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. GSK Recent Developments/Updates
    Table 76. GSK Competitive Strengths & Weaknesses
    Table 77. Otsuka Pharmaceutical Basic Information, Area Served and Competitors
    Table 78. Otsuka Pharmaceutical Major Business
    Table 79. Otsuka Pharmaceutical Depression Drugs Product and Services
    Table 80. Otsuka Pharmaceutical Depression Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Otsuka Pharmaceutical Recent Developments/Updates
    Table 82. Otsuka Pharmaceutical Competitive Strengths & Weaknesses
    Table 83. Takeda Basic Information, Area Served and Competitors
    Table 84. Takeda Major Business
    Table 85. Takeda Depression Drugs Product and Services
    Table 86. Takeda Depression Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Takeda Recent Developments/Updates
    Table 88. Takeda Competitive Strengths & Weaknesses
    Table 89. NHU Group Basic Information, Area Served and Competitors
    Table 90. NHU Group Major Business
    Table 91. NHU Group Depression Drugs Product and Services
    Table 92. NHU Group Depression Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. NHU Group Recent Developments/Updates
    Table 94. NHU Group Competitive Strengths & Weaknesses
    Table 95. Shionogi Basic Information, Area Served and Competitors
    Table 96. Shionogi Major Business
    Table 97. Shionogi Depression Drugs Product and Services
    Table 98. Shionogi Depression Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. Shionogi Recent Developments/Updates
    Table 100. Shionogi Competitive Strengths & Weaknesses
    Table 101. APOTEX Basic Information, Area Served and Competitors
    Table 102. APOTEX Major Business
    Table 103. APOTEX Depression Drugs Product and Services
    Table 104. APOTEX Depression Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. APOTEX Recent Developments/Updates
    Table 106. APOTEX Competitive Strengths & Weaknesses
    Table 107. Kanghong Pharma Basic Information, Area Served and Competitors
    Table 108. Kanghong Pharma Major Business
    Table 109. Kanghong Pharma Depression Drugs Product and Services
    Table 110. Kanghong Pharma Depression Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. Kanghong Pharma Recent Developments/Updates
    Table 112. HUAHAI Basic Information, Area Served and Competitors
    Table 113. HUAHAI Major Business
    Table 114. HUAHAI Depression Drugs Product and Services
    Table 115. HUAHAI Depression Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 116. Global Key Players of Depression Drugs Upstream (Raw Materials)
    Table 117. Depression Drugs Typical Customers
List of Figure
    Figure 1. Depression Drugs Picture
    Figure 2. World Depression Drugs Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Depression Drugs Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Depression Drugs Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Depression Drugs Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Depression Drugs Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Depression Drugs Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Depression Drugs Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Depression Drugs Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Depression Drugs Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Depression Drugs Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Depression Drugs Revenue (2019-2030) & (USD Million)
    Figure 13. Depression Drugs Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Depression Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Depression Drugs Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Depression Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Depression Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Depression Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Depression Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Depression Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Depression Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Depression Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Depression Drugs by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Depression Drugs Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Depression Drugs Markets in 2023
    Figure 27. United States VS China: Depression Drugs Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Depression Drugs Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Depression Drugs Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Depression Drugs Market Size Market Share by Type in 2023
    Figure 31. SSRIs
    Figure 32. SNRIs
    Figure 33. Others
    Figure 34. World Depression Drugs Market Size Market Share by Type (2019-2030)
    Figure 35. World Depression Drugs Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 36. World Depression Drugs Market Size Market Share by Application in 2023
    Figure 37. Hospitals
    Figure 38. Clinics
    Figure 39. Others
    Figure 40. Depression Drugs Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Companies Mentioned

Intellipharmaceutics
Pfizer
Eli Lilly
Astrazeneca
Lundbeck
Allergan
GSK
Otsuka Pharmaceutical
Takeda
NHU Group
Shionogi
APOTEX
Kanghong Pharma
HUAHAI